Nilsine Partners, LLC Dexcom Inc Transaction History

Nilsine Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$86.06 - $137.93 $258 - $413	-3 Reduced 0.13%	2,355 $220 Million
Q2 2023 Jul 21, 2023	BUY	$112.47 - $130.98 $3,936 - $4,584	35 Added 1.51%	2,358 $303 Million
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $241,592 - $285,543	2,323 New	2,323 $270 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Nilsine Partners, LLC with notifications on news.